Study identifies antidepressants that get patients well and keep them well
A large-scale study finds Lexapro outperforms Prozac for long-term depression, while the second-ranked drug remains unavailable in the US.
10 trends tracked about this subject — the full history, oldest to newest below.
A large-scale study finds Lexapro outperforms Prozac for long-term depression, while the second-ranked drug remains unavailable in the US.
An experimental weight-loss drug significantly eased knee pain in two major new trials, according to coverage from Everyday Health.
Coverage explores unexpected side effects, mental health impacts, and generational patterns surrounding GLP-1 medications.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A minimally invasive, image-guided hydrodissection technique emerges as a lasting relief option for carpal tunnel syndrome.
Recent reporting examines health conditions linked to larger breast sizes, highlighting specific physical impacts.
GLP-1 medications are shifting from clinical obesity treatments for patients to lifestyle products for customers, amid a surge in oral pill options.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent discussions highlight a shift in the narrative surrounding weight-loss drugs, focusing on gender dynamics and the desire for medical privacy.